This issue of Weizmann Views features Dr. Jacob Hanna, an MD/PhD who is one of the world's leaders in stem cell research. His methods for quickly, efficiently producing induced pluripotent stem (iPS) cells and for ""resetting"" iPS cells to their earliest possible state could change the face of medicine, including growing organs on demand.
The Weizmann Institute's stellar astrophysics team is developing a small, light satellite that will be equipped with a telescope searching in the ultraviolet range for events such as supernovas and black holes. The team is collaborating with Caltech and NASA, among others, on the satellite, which is a first for Weizmann – and for Israel.
At the Weizmann Institute, scientists from a range of disciplines are investigating the causes and nature of Alzheimer's disease, as well as looking for ways to slow or stop its progress, and for new and better treatments.
According to the American Heart Association, more than 80 million Americans have one or more forms of cardiovascular disease. Weizmann researchers are not only searching for solutions to this health epidemic, but are also investigating the very earliest causes, such as problems during embryonic formation.
Like police detectives using DNA fingerprinting, Weizmann cancer researchers are building a DNA profile of malignancy in an attempt to eradicate cancer.
Weizmann scientists are unlocking the secrets of plant metabolism, genetics, and development and are concentrating their biochemical, molecular, and genomics-oriented research to eliminate hunger and malnutrition in developing countries, and to improve human health all over the world.
December 11, 2012
Weizmann President Prof. Daniel Zajfman speaks to Haaretz about knowledge, curiosity, and passion – his recipe for success – and how he has applied this formula to developing long-term strategies for the Institute. He also talks about finding happiness in work and in life: ""Ask yourself what you love to do – and then do it.""
December 02, 2012
Prof. Tony Futerman studies lipids – fatty substances found in every cell in our bodies. A type called sphingolipids builds up in harmful amounts due to some genetic diseases, such as Gaucher's. Understanding this process could lead to new and better therapies.
Blood cancers, such as lymphoma and leukemia, arise due to errors in the genetic information of an immature blood cell – and they often affect children. In fact, leukemia alone is responsible for 40 percent of pediatric cancers. Read how Weizmann scientists are helping.
©2019 American Committee for the Weizmann Institute of Science
